MedPath

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon

Not Applicable
Completed
Conditions
Dermal Irritation
Interventions
Device: Trojan "Chameleon" Personal Lubricant
Registration Number
NCT02737618
Lead Sponsor
Church & Dwight Company, Inc.
Brief Summary

to determine the ability of the test article to cause irritation to the skin of humans under controlled patch test conditions

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • male or female, 18-70 years of age, in general good health
  • normal skin
  • free of any systemic or dermatologic disorder which, in the opinion of the investigative personnel, will interfere with the study results or increase the risk of adverse events
  • of any skin type or race providing the skin pigmentation will allow discernment of erythema
  • agree to complete a medical history and concomitant medication form
  • read, understand and sign informed consent
Exclusion Criteria
  • have any visible skin disease at the study site which, in the opinion of the investigative personnel, will interfere with the evaluation
  • are receiving systemic or topical drugs or medication which, in the opinion of the investigative personnel, will interfere with the study results
  • have psoriasis and/or active atopic dermatitis/eczema
  • have a known sensitivity to cosmetics, skin care test articles, or topical drugs as related to the test article being evaluated
  • are females who are pregnant or breastfeeding or become pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Healthy subjectTrojan "Chameleon" Personal LubricantHealthy subjects exposed to Trojan "Chameleon" Personal Lubricant applied by occlusive patch
Primary Outcome Measures
NameTimeMethod
Number of Subjects That Showed Erythema Based on 5 Point Scoring Scale14 days
Number of Subjects That Showed Edema Based on the 5 Point Scoring Scale14 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

TKL Research Inc

🇺🇸

Fair Lawn, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath